Almirall
Sergio Lavilla-Alonso is a highly experienced researcher and leader in the fields of immuno-oncology and dermatology. Currently serving as a Principal Investigator and Project Leader at Almirall since March 2021, Sergio manages a multi-specific antibody development program and leads novel target validation efforts for dermatology diseases while participating in the evaluation of biological assets for dermato-oncology. Previously, Sergio held roles as a Scientific Advisor at BIG against breast cancer, a Translational Research Scientist at Genmab, and a Scientist in Immuno-Oncology at Janssen EMEA. Academic achievements include a PhD from the University of Helsinki and a Master of Pharmacy from Universitat de Barcelona, alongside post-doctoral research and various consulting positions, highlighting a strong commitment to advancing cancer therapies through innovative research and collaboration.
This person is not in any teams
This person is not in any offices
Almirall
12 followers
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents.